Premium
How we manage prostate biopsy and prostate cancer therapy in men with haemophilia
Author(s) -
FOGARTY P. F.,
KOUIDES P.
Publication year - 2012
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2012.02787.x
Subject(s) - medicine , rectal examination , prostate cancer , haemophilia , prostate , prostate biopsy , family history , biopsy , prostate specific antigen , oncology , haemophilia a , cancer , surgery
A 56‐year‐old African American male with severe haemophilia A [baseline factor VIII (FVIII) activity <1%] and chronic hepatitis C virus infection started annual serial monitoring of prostate‐specific antigen (PSA) at age 40 because of a family history of prostate cancer (his father died from the disease at age 63). His most recent PSA level was 4.4 ng L−1; previous values were <3 ng L −1 . Digital rectal examination was unrevealing.